HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

…, DW Johnson, JC Craig, GF Strippoli - … of systematic reviews, 2009 - europepmc.org
Background Dyslipidaemia occurs frequently in chronic kidney disease (CKD) patients and
contributes both to cardiovascular disease and worsening renal function. Statins are widely …

[HTML][HTML] The Italian experience of the national registry of renal biopsies

L Gesualdo, AM Di Palma, LF Morrone, GF Strippoli… - Kidney international, 2004 - Elsevier
… Author links open overlay panel Loreto Gesualdo , Anna Maria Di Palma , Luigi Francesco
Morrone , Giovanni Fabrizio Strippoli , Francesco Paolo Schena , on behalf of the Italian …

Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.

KS Rabindranath, GF Strippoli, C Daly… - … of systematic reviews, 2006 - europepmc.org
Background Renal replacement therapy (RRT) for end-stage kidney disease (ESKD) can be
achieved by several interventions including haemodialysis (HD), peritoneal dialysis (PD) …

[PDF][PDF] Clinical and therapeutic aspects of diabetic nephropathy

GF Strippoli, S Di Paolo, R Cincione, AM Di Palma… - population, 2003 - researchgate.net
487-499 Strippoli Page 1 487 INTRODUCTION The prognosis of renal survival in both type
1 and type 2 diabetes mellitus is not benign. Overt diabetic nephropathy occurs in 30-40% of …

Diagnostic performance of non-invasive imaging for stable coronary artery disease: A meta-analysis

…, MG Rabbat, F Cademartiri, GF Strippoli - International Journal of …, 2020 - Elsevier
Background To determine diagnostic performance of non-invasive tests using invasive
fractional flow reserve (FFR) as reference standard for coronary artery disease (CAD). Methods …

Haemoglobin and haematocrit targets for the anaemia of chronic renal disease.

GF Strippoli, C Manno, FP Schena… - The Cochrane Database …, 2003 - europepmc.org
BACKGROUND: Anaemia affects 60-80% of patients with renal impairment, reduces quality
of life and is a risk factor for early death. Treatment options are blood transfusion, …

[PDF][PDF] Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) randomized trial

…, L Gesualdo, F Pellegrini, GF Strippoli - Journal of …, 2007 - researchgate.net
Microalbuminuria is a strong, consistent and independent risk factor for cardiovascular and
renal disease in patients with diabetes and/or hypertension and in the general population. …

Evidence for optimal hemoglobin targets in chronic kidney disease.

…, C Bonifati, FP Schena, GF Strippoli - Journal of …, 2006 - europepmc.org
Even though anemia occurs frequently in patients with chronic kidney disease and therapeutic
options are widely available, the ideal hemoglobin target level is not clearly established. …

[PDF][PDF] Should we shift toward higher blood pressure targets in patients with chronic kidney disease

G Gentile, GF Strippoli - J Nephrol, 2011 - academia.edu
Hypertension is the leading cause of death worldwide and is responsible for a significantly
increased burden of cardiovascular events and progression to endstage kidney disease in …

Calcimimetics, phosphate binders, vitamin D and its analogues for treating secondary hyperparathyroidism in chronic kidney disease: guideline from the Italian …

…, M Cozzolino, M Marangella, GF Strippoli… - Giornale Italiano di …, 2007 - europepmc.org
Background The current 3rd edition of the Italian Society of Nephrology guidelines has
been drawn up to summarize evidence of key intervention issues on the basis of systematic …